Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days 1.22€ 1.22€ Friday, 22nd Dec 2023 PHGN.F stock ended at 1.22€. During the day the stock fluctuated 0% from a day low at 1.22€ to a day high of 1.22€.
90 days 1.20€ 1.22€
52 weeks 0.92€ 1.48€

Historical Pharming Group N.V. prices

Date Open High Low Close Volume
Feb 07, 2023 1.24€ 1.24€ 1.24€ 1.24€ 0
Feb 06, 2023 1.24€ 1.24€ 1.23€ 1.23€ 0
Feb 03, 2023 1.22€ 1.25€ 1.22€ 1.25€ 0
Feb 02, 2023 1.23€ 1.24€ 1.23€ 1.24€ 0
Feb 01, 2023 1.27€ 1.27€ 1.25€ 1.25€ 0
Jan 31, 2023 1.24€ 1.24€ 1.24€ 1.24€ 0
Jan 30, 2023 1.30€ 1.30€ 1.28€ 1.28€ 0
Jan 27, 2023 1.27€ 1.30€ 1.27€ 1.30€ 0
Jan 26, 2023 1.28€ 1.28€ 1.27€ 1.28€ 0
Jan 25, 2023 1.24€ 1.27€ 1.24€ 1.27€ 0
Jan 24, 2023 1.29€ 1.29€ 1.25€ 1.25€ 0
Jan 23, 2023 1.33€ 1.34€ 1.30€ 1.30€ 0
Jan 20, 2023 1.32€ 1.33€ 1.32€ 1.32€ 0
Jan 19, 2023 1.34€ 1.34€ 1.33€ 1.33€ 1 442
Jan 18, 2023 1.37€ 1.37€ 1.34€ 1.34€ 0
Jan 17, 2023 1.30€ 1.40€ 1.30€ 1.38€ 1 442
Jan 16, 2023 1.20€ 1.20€ 1.20€ 1.20€ 0
Jan 13, 2023 1.17€ 1.21€ 1.17€ 1.21€ 0
Jan 12, 2023 1.16€ 1.19€ 1.16€ 1.19€ 0
Jan 11, 2023 1.15€ 1.15€ 1.14€ 1.14€ 0
Jan 10, 2023 1.13€ 1.15€ 1.13€ 1.15€ 0
Jan 09, 2023 1.11€ 1.11€ 1.11€ 1.11€ 0
Jan 06, 2023 1.14€ 1.14€ 1.14€ 1.14€ 0
Jan 05, 2023 1.13€ 1.13€ 1.13€ 1.13€ 0
Jan 04, 2023 1.15€ 1.15€ 1.15€ 1.15€ 0
Click to get the best stock tips daily for free!

About Pharming Group N.V.

Pharming Group N.V. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment ... PHGN.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT